Chinese tech stocks sink as Alibaba hits record-low in Hong Kong amid price cuts, Fed concerns while city battles Covid-19 outbreaks
- More than 20 analysts have trimmed their price targets for Alibaba Group over the past month, including at least three this week, according to Bloomberg data
- Goldman Sachs cut Alibaba Health to neutral from buy as stock lost more than 9 per cent this year

The Hang Seng Index retreated 2 per cent to 23,664.80 at the close of Thursday trading after slumping as much as 3 per cent in the worst day since September 20. The Tech Index tumbled 3.8 per cent, the most in three weeks, while China’s Shanghai Composite Index lost 1.8 per cent.
Alibaba Healthcare Information slipped 4.3 per cent to HK$5.99 after Goldman Sachs downgraded the stock to neutral from buy on Thursday, with a price target of HK$8. The stock has lost 9.1 per cent this year.
Higher borrowing costs “are likely to continue to pressure highly valued part of the equity market,” Kelly Craig, global market strategist at JPMorgan Asset Management, said after the Fed decision. “Yields should rise, but growth worries may keep investors cautious in the near term.”

The Federal Reserve plans to raise interest rates soon to fight inflation, roiling US stocks and cryptocurrencies this month. It expects to start bond-tapering after lift-off to fight US inflation at 39-year high, it added.